Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 193 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Income Statement [Abstract]      
Net sales $ 0 $ 0 $ 69,000
Cost of goods sold 0 0 24,120
Gross profit 0 0 44,880
Operating expenses 924,987 1,168,384 63,879,267
Research and development expenses 451,987 373,555 11,133,154
Non-cash patent settlement cost 0 0 1,610,066
Loss before other income (expense) (1,376,974) (1,541,939) (76,577,607)
Other income (loss) (26,500) (28,845) 166,300
Interest income 0 0 16,342
Interest and financing expense 0 (260) (20,304,609)
Gain (loss) due to change in fair value of derivative liabilities 0 (220,614) (2,115,507)
Gain on extinguishment of derivative liabilities 0 3,441,752 5,886,847
Costs of private placement 0 0 (1,640,715)
Costs to induce conversion of notes 0 0 (469,043)
Gain on disposition of equipment 0 0 27,497
Settlement of Debt Due Morale/ Matthews 0 0 (927,903)
Settlement of litigation and debt 0 (67,294) 1,505,143
Net income (loss) before provision for income taxes (1,403,474) 1,582,800 (94,433,255)
Provision for income taxes 0 0 9,082
Net income (loss) $ (1,403,474) $ 1,582,800 $ (94,442,337)
Net income (loss) per common share, basic $ (0.01) $ 0.01  
Net income (loss) per share, diluted $ (0.01) $ 0.01  
Weighted average common shares outstanding, basic 179,341,951 150,112,286  
Weighted average common shares outstanding, diluted 179,341,951 172,461,669